Funding Pressures Impact Non-Originator Drugs In Germany, France and Italy

November 1, 2017

Pressure on public finances has led national governments across Europe to seek better control over healthcare expenditure. Healthcare funding pressure varies from country to country. However, pharmaceutical products are generally seen as a prime area where savings can be achieved. One way governments are looking to contain this area of expenditure is through shifting pharmaceutical consumption away from expensive branded products towards cheaper non-originator drugs (i.e. generics and biosimilars).

Download Report

Competition and Markets Authority’s Care Homes Market Study

August 1, 2017

In December 2016, the Competition and Markets Authority (CMA) began a market study into care homes. The purpose was to explore how well the care home market works for residents and their families, and to review providers’ compliance with consumer protection law. They recently published their interim findings and where they intend to focus their investigation ahead of the final report publication by December 2017.

Download Report

England’s Changing Primary Care Landscape

July 1, 2017

Primary care in England is changing. This is the result of a combination of national policy drivers, regulatory and contracting enablers, and service redesign.

Download Report

Conservative Manifesto: A Reduced Role for Private Payers in Social Care

May 1, 2017

The publication of the Conservative manifesto last week highlighted a trend that followers of health and care policy making have seen for the last 6 months – the rise of adult social care on the political agenda

Download Report